Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar

Clinical trial NCT00174226 · COMPLETED

Trial details

NCT number: NCT00174226
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Attention Deficit Disorder With Hyperactivity

Start date: 2004-11-01
Enrollment: 241

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.